David Zagzag

32.6k total citations · 5 hit papers
258 papers, 19.3k citations indexed

About

David Zagzag is a scholar working on Genetics, Molecular Biology and Neurology. According to data from OpenAlex, David Zagzag has authored 258 papers receiving a total of 19.3k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Genetics, 63 papers in Molecular Biology and 62 papers in Neurology. Recurrent topics in David Zagzag's work include Glioma Diagnosis and Treatment (105 papers), Cancer, Hypoxia, and Metabolism (43 papers) and MRI in cancer diagnosis (24 papers). David Zagzag is often cited by papers focused on Glioma Diagnosis and Treatment (105 papers), Cancer, Hypoxia, and Metabolism (43 papers) and MRI in cancer diagnosis (24 papers). David Zagzag collaborates with scholars based in United States, Canada and Germany. David Zagzag's co-authors include Glyn Johnson, Meng Law, Edmond A. Knopp, Gregg L. Semenza, Jonathan W. Simons, Soonmee Cha, Elizabeth W. Newcomb, James S. Babb, Erik Laughner and George D. Yancopoulos and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

David Zagzag

257 papers receiving 18.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

1999 1.9k citations David Zagzag, Gregg L. Semenza et al. profile →
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF

1999 1.7k citations David Zagzag et al. profile →
Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging

2003 803 citations Meng Law, Stanley Yang et al. American Journal of Neuroradiology profile →
Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts

1999 734 citations David Zagzag et al. profile →
Expression of hypoxia-inducible factor 1? in brain tumors

2000 515 citations David Zagzag, Gregg L. Semenza et al. profile →

Peers

Countries citing papers authored by David Zagzag

Since Specialization

Citations

This map shows the geographic impact of David Zagzag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Zagzag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Zagzag more than expected).

Fields of papers citing papers by David Zagzag

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Zagzag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Zagzag. The network helps show where David Zagzag may publish in the future.

Co-authorship network of co-authors of David Zagzag

This figure shows the co-authorship network connecting the top 25 collaborators of David Zagzag. A scholar is included among the top collaborators of David Zagzag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Zagzag. David Zagzag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	T2-FLAIR Mismatch Sign Predicts DNA Methylation Subclass and CDKN2A/B Status in IDH -Mutant Astrocytomas 2024 ·Clinical Cancer Research ·Matthew Lee, Rajan Jain, Kristyn Galbraith, (unknown), (unknown), Sohil H. Patel, Dimitris G. Placantonakis, David Zagzag, (unknown), (unknown), John G. Golfinos, Daniel A. Orringer, Matija Snuderl	2
2	Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma 2023 ·Clinical Cancer Research ·Sylvia C. Kurz, Elçin Zan, (unknown), Andrea B. Troxel, (unknown), Joshua S. Silverman, Matija Snuderl, David Zagzag, Douglas Kondziolka, John G. Golfinos, Andrew Chi, Erik P. Sulman	23
3	Growth hormone secreting pituitary carcinomas: Case report and review of literature 2021 ·Growth Hormone & IGF Research ·(unknown), Fei Chen, Elçin Zan, Christopher William, Chandranath Sen, Richard A. Lebowitz, David Zagzag, Floyd A. Warren, Tamar Brandler, Nidhi Agrawal	2
4	Hemorrhagic stroke and anticoagulation in COVID-19 2020 ·Journal of Stroke and Cerebrovascular Diseases ·Siddhant Dogra, Rajan Jain, Meng Cao, Seda Bilaloglu, David Zagzag, Sarah Hochman, Ariane Lewis, Kara Melmed, Katherine Hochman, Leora I. Horwitz, Steven Galetta, Jeffrey S. Berger	127
5	Serial Imaging of Virus-Associated Necrotizing Disseminated Acute Leukoencephalopathy (VANDAL) in COVID-19 2020 ·American Journal of Neuroradiology ·Shashank Agarwal, (unknown), Vinh Nguyen, Siddhant Dogra, Penina Krieger, David Zagzag, Ariane Lewis, Kara Melmed, Steven Galetta, Rajan Jain	11
6	Pediatric midline H3K27M-mutant tumor with disseminated leptomeningeal disease and glioneuronal features: case report and literature review 2020 ·Child s Nervous System ·(unknown), Danielle Golub, Travis C. Hill, (unknown), Christopher William, David Zagzag, Eveline Teresa Hidalgo	10
7	COVID-19-Induced Neurovascular Injury: a Case Series with Emphasis on Pathophysiological Mechanisms 2020 ·SN Comprehensive Clinical Medicine ·(unknown), Rajan Jain, George Kleinman, Carrie R. Muh, (unknown), Rebecca D. Folkerth, Matija Snuderl, Dimitris G. Placantonakis, Steven Galetta, Sarah Hochman, David Zagzag	18
8	Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor 2016 ·Neoplasia ·N. Sumru Bayın, Lin Ma, Cheddhi Thomas, (unknown), (unknown), (unknown), Mark Bustoros, John G. Golfinos, Donato Pacione, Matija Snuderl, David Zagzag, Mary Helen Barcellos‐Hoff, Dimitris G. Placantonakis	28
9	Decreased Expression of Cystathionine β-Synthase Promotes Glioma Tumorigenesis 2014 ·Molecular Cancer Research ·Naoharu Takano, Yasmeen Sarfraz, Daniele M. Gilkes, Pallavi Chaturvedi, Lisha Xiang, Makoto Suematsu, David Zagzag, Gregg L. Semenza	53
10	Merlin/NF2 Loss-Driven Tumorigenesis Linked to CRL4DCAF1-Mediated Inhibition of the Hippo Pathway Kinases Lats1 and 2 in the Nucleus 2014 ·Cancer Cell ·Wei Li, Jonathan M. Cooper, Lü Zhou, Chenyi Yang, Hediye Erdjument‐Bromage, David Zagzag, Matija Snuderl, Marc Ladanyi, C. Oliver Hanemann, Pengbo Zhou, Matthias A. Karajannis, Filippo G. Giancotti	183
11	Mechanisms of Glioma-Associated Neovascularization 2012 ·American Journal Of Pathology ·Matthew E. Hardee, David Zagzag	346
12	Glutamic Acid Decarboxylase Autoantibody Syndrome Presenting as Schizophrenia 2012 ·The Neurologist ·Souhel Najjar, Daniel M. Pearlman, David Zagzag, John G. Golfinos, Orrin Devinsky	21
13	Aurora A Is a Repressed Effector Target of the Chromatin Remodeling Protein INI1/hSNF5 Required for Rhabdoid Tumor Cell Survival 2011 ·Cancer Research ·Seung‐Jae Lee, Velasco Cimica, Nandini Ramachandra, David Zagzag, Ganjam V. Kalpana	70
14	Multicentric Castleman’s Disease of the Central Nervous System 2011 ·Clinical Neuroradiology ·Rahul V. Pawar, (unknown), David Zagzag, Erik Parker, A. Narayana	1
15	INI1 Induces Interferon Signaling and Spindle Checkpoint in Rhabdoid Tumors 2007 ·Clinical Cancer Research ·(unknown), Seung Jae Lee, Zhikai Zhang, Velasco Cimica, David Zagzag, Ganjam V. Kalpana	32
16	BRAINSTEM CORTICOSPINAL TRACT DIFFUSION TENSOR IMAGING IN PATIENTS WITH PRIMARY POSTERIOR FOSSA NEOPLASMS STRATIFIED BY TUMOR TYPE 2007 ·Neurosurgery ·Yvonne W. Lui, Meng Law, (unknown), James S. Babb, (unknown), Jeffrey C. Allen, David Zagzag, Glyn Johnson	18
17	IFN-γ Determines Distinct Clinical Outcomes in Autoimmune Encephalomyelitis 2005 ·The Journal of Immunology ·Allen Wensky, Gláucia C. Furtado, Maria Cecília Garibaldi Marcondes, Shaohua Chen, Denise Manfra, Sérgio A. Lira, David Zagzag, Juan J. Lafaille	85
18	Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging breakdown → 2003 ·American Journal of Neuroradiology ·Meng Law, Stanley Yang, Hao Wang, James S. Babb, Glyn Johnson, Soonmee Cha, Edmond A. Knopp, David Zagzag	803
19	Anticopper treatment inhibits pseudopodial protrusion and the invasive spread of 9L gliosarcoma cells in the rat brain 1990 ·Neurosurgery ·Steven Brem, Ana Maria Crous Tsanaclis, David Zagzag	66
20	Angiogenesis and Blood-Brain Barrier Breakdown Modulate CT Contrast Enhancement: An Experimental Study in a Rabbit Brain-Tumor Model 1989 ·American Journal of Neuroradiology ·David Zagzag, Marvin M. Goldenberg, Steven Brem	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact